Viewing Study NCT03775733


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-02-25 @ 4:36 PM
Study NCT ID: NCT03775733
Status: UNKNOWN
Last Update Posted: 2020-05-08
First Post: 2018-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia
Sponsor: Chonbuk National University Hospital
Organization:

Study Overview

Official Title: A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate The Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia
Status: UNKNOWN
Status Verified Date: 2020-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study was conducted to investigate the effects of daily supplementation of hydrolysed red ginseng extract on improvement of Hyperglycemia.
Detailed Description: This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Hydrolysed Red Ginseng extract or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: